Nutra Pharma Completes FDA Submission for Nyloxin OTC, Rx

Nutra Pharma Corp. … has announced Monday that it has successfully submitted the final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Nyloxin OTC, an over-the-counter treatment for moderate to severe (Stage 2) chronic pain, and Nyloxin Rx, a prescription treatment for severe (Stage 3) chronic pain.
Yahoo!